199 related articles for article (PubMed ID: 15980157)
1. Novel targeted therapies in the treatment of gastric and esophageal cancer.
Tabernero J; Macarulla T; Ramos FJ; Baselga J
Ann Oncol; 2005 Nov; 16(11):1740-8. PubMed ID: 15980157
[TBL] [Abstract][Full Text] [Related]
2. Novel targets in gastric and esophageal cancer.
Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapies in the treatment of gastric cancer.
Ngeow J; Tan IB; Choo SP
Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
[TBL] [Abstract][Full Text] [Related]
4. Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies.
Cappetta A; Lonardi S; Pastorelli D; Bergamo F; Lombardi G; Zagonel V
Crit Rev Oncol Hematol; 2012 Jan; 81(1):38-48. PubMed ID: 21256046
[TBL] [Abstract][Full Text] [Related]
5. Current and Emerging Systemic Therapy in Gastro-Esophageal Cancer "The Old and New Therapy for Metastatic Disease, The Role of Adjuvant and Neoadjuvant Therapy for Localized Disease".
Lim B; Jiang Y
Curr Clin Pharmacol; 2015; 10(4):267-78. PubMed ID: 26548904
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers and novel agents in esophago-gastric cancer: are we making progress?
Dahle-Smith A; Petty RD
Expert Rev Anticancer Ther; 2015; 15(9):1103-19. PubMed ID: 26313419
[TBL] [Abstract][Full Text] [Related]
7. Novel targeted therapies for advanced esophageal cancer.
Lin CC; Papadopoulos KP
Dis Esophagus; 2007; 20(5):365-71. PubMed ID: 17760648
[TBL] [Abstract][Full Text] [Related]
8. Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer.
Sutter AP; Zeitz M; Scherübl H
Onkologie; 2004 Feb; 27(1):17-21. PubMed ID: 15007244
[TBL] [Abstract][Full Text] [Related]
9. Gastric Carcinoma at the Era of Targeted Therapies.
Dreanic J; Dhooge M; Sion E; Brezault C; Chaussade S; Coriat R
Curr Drug Targets; 2016; 17(15):1818-1826. PubMed ID: 25944013
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy for advanced esophagogastric adenocarcinoma.
Kordes S; Cats A; Meijer SL; van Laarhoven HW
Crit Rev Oncol Hematol; 2014 Apr; 90(1):68-76. PubMed ID: 24183912
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic esophagus and gastric cancer.
Shah MA; Schwartz GK
Semin Oncol; 2004 Aug; 31(4):574-87. PubMed ID: 15297948
[TBL] [Abstract][Full Text] [Related]
12. Novel targets in esophageal and gastric cancer: beyond antiangiogenesis.
Lee W; Patel JH; Lockhart AC
Expert Opin Investig Drugs; 2009 Sep; 18(9):1351-64. PubMed ID: 19642951
[TBL] [Abstract][Full Text] [Related]
13. [Second-line treatment for metastatic or locally advanced gastric cancer].
Li KC; Cheng SY; Du J; Li J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):721-724. PubMed ID: 27784452
[TBL] [Abstract][Full Text] [Related]
14. Update on metastatic gastric and esophageal cancers.
Shah MA
J Clin Oncol; 2015 Jun; 33(16):1760-9. PubMed ID: 25918288
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy for oesophageal cancer: an overview.
Syrigos KN; Zalonis A; Kotteas E; Saif MW
Cancer Metastasis Rev; 2008 Jun; 27(2):273-88. PubMed ID: 18224295
[TBL] [Abstract][Full Text] [Related]
16. Esophagogastric cancer: targeted agents.
Ku GY; Ilson DH
Cancer Treat Rev; 2010 May; 36(3):235-48. PubMed ID: 20122806
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapies in gastric cancer treatment: where we are and where we are going.
Tomasello G; Ghidini M; Liguigli W; Ratti M; Toppo L; Passalacqua R
Invest New Drugs; 2016 Jun; 34(3):378-93. PubMed ID: 26873643
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight.
Aprile G; Ongaro E; Del Re M; Lutrino SE; Bonotto M; Ferrari L; Rihawi K; Cardellino GG; Pella N; Danesi R; Fasola G
Crit Rev Oncol Hematol; 2015 Aug; 95(2):165-78. PubMed ID: 25800976
[TBL] [Abstract][Full Text] [Related]
19. Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignancies.
Kim S; Barzi A; Rajdev L
Semin Oncol; 2018 Jun; 45(3):133-150. PubMed ID: 30262395
[TBL] [Abstract][Full Text] [Related]
20. Esophagogastric cancer: integration of targeted therapies into systemic chemotherapy.
Moehler M; Schwarz S; Wagner AD
Curr Cancer Drug Targets; 2011 Jul; 11(6):681-7. PubMed ID: 21651462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
